Biogenity ApS: Financial statements 2021
CVR: 39606925
Source: annual report 2021, Danish Business Authority
01/07/2020 – 30/06/2021
Biogenity ApS (CVR 39606925) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 96,977 and a net result of DKK 117,322 compared with DKK 71,526 the year before. Equity in the 2021 report amounted to DKK 250,138. The solvency ratio was 49.8%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 96,977
- Profit/Loss
- DKK 117,322
- Equity
- DKK 250,138
- Total Assets
- DKK 502,476
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 97 t. | 117 t. | 250 t. | 3 |
| 2020 | - | -115 t. | 72 t. | 133 t. | - |
| 2019 | - | -71 t. | 141 t. | 141 t. | - |
Official annual report
Find more companies like Biogenity ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorAbout Biogenity ApS
Biogenity ApS is a Danish company of the type Anpartsselskab based in Aalborg Øst, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Kenneth Kastaniegaard and Louis Loeb. The board consists of Louis Loeb (chair) and Kenneth Kastaniegaard. The company is owned by L.Loeb Holding ApS and Kastaniegaard Holding ApS. According to the 2025 annual report, the company had an average of 4 employees. In 2025, the company reported a gross profit of DKK 1,387,873 and a net result of DKK -453,753 compared with DKK -342,877 the year before. Equity in the 2025 report amounted to DKK -189,867.